miglustat
Miglustat is used to treat adults with mild-to-moderate type I Gaucher disease for whom enzyme replacement therapy is unsuitable. It is marketed under the trade name Zavesca. Reference standards of Miglustat API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => (2R,3R,4R,5S)-3,4,5-Tris(benzyloxy)-2-((benzyloxy)methyl)-1-butylpiperidine
[catalogue_number] => PA 13 2131003
[category_ids] => ,76,82,78,95,
[chemical_name] =>
[weight] => 579.78
[form] => C38H45NO4
[cas] => 227932-82-3
[pslug] => 227932-82-3-2r-3r-4r-5s-3-4-5-tris-benzyloxy-2-benzyloxy-methyl-1-butylpiperidine-pa132131003
[latest_product] => 0
[linkproducts] => 1
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(2R,3R,4R,5S)-3,4,5-Tris(benzyloxy)-2-((benzyloxy)methyl)-1-butylpiperidine
Catalogue No.:PA 13 2131003
Molecular Formula : C38H45NO4
Molecular Weight : 579.78